Insights from the Glut1 Deficiency Collective Voices Project, which surveyed over 260 individuals across 31 countries, highlight common barriers to sustained KT use: side effects, social restrictions, time demands, lack of trained professionals, and food-related misconceptions (Foundation, 2022). This evidence concerns the gene SLC2A1 and hyperinsulinemic hypoglycemia, familial, 4.